We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$82.1B
AUM Growth
+$7.21B
Cap. Flow
+$2.14B
Cap. Flow %
2.6%
Top 10 Hldgs %
34.14%
Holding
3,101
New
616
Increased
843
Reduced
896
Closed
659

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$495M
2
SPOT icon
Spotify
SPOT
+$377M
3
HUM icon
Humana
HUM
+$350M
4
GS icon
Goldman Sachs
GS
+$324M
5
MRK icon
Merck
MRK
+$307M

Sector Composition

Rank Sector Weight
1 Technology 18.11%
2 Consumer Discretionary 14.61%
3 Healthcare 12.89%
4 Industrials 6.78%
5 Financials 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMUS icon
526
T-Mobile US
TMUS
$193B
$18M 0.02%
+87,100
New +$16.7M
ITRI icon
527
Itron
ITRI
$3.73B
$17.9M 0.02%
167,804
-18,894
-10% -$1.91M
HAE icon
528
Haemonetics
HAE
$3.58B
$17.9M 0.02%
222,881
+177,989
+396% +$14.4M
RIVN icon
529
Rivian
RIVN
$22.9B
$17.8M 0.02%
1,586,146
+947,869
+149% +$13.6M
LGIH icon
530
LGI Homes
LGIH
$1.4B
$17.7M 0.02%
149,562
-120,236
-45% -$12.7M
NHI icon
531
National Health Investors
NHI
$3.9B
$17.7M 0.02%
+210,873
New +$16.3M
DXCM icon
532
DexCom
DXCM
$27.6B
$17.7M 0.02%
264,000
-87,305
-25% -$7.17M
TECK icon
533
Teck Resources
TECK
$29.5B
$17.7M 0.02%
338,024
+110,420
+49% +$5.26M
CGEM icon
534
Cullinan Oncology
CGEM
$1.05B
$17.6M 0.02%
1,053,764
-130,273
-11% -$2.31M
KOF icon
535
Coca-Cola Femsa
KOF
$21.6B
$17.6M 0.02%
198,319
+108,522
+121% +$9.48M
RVLV icon
536
Revolve Group
RVLV
$1.79B
$17.6M 0.02%
709,369
+230,746
+48% +$4.84M
UTZ icon
537
Utz Brands
UTZ
$1.25B
$17.5M 0.02%
990,280
+177,634
+22% +$2.95M
VSTS icon
538
Vestis
VSTS
$2.06B
$17.5M 0.02%
1,174,149
+232,102
+25% +$3.12M
CFG icon
539
Citizens Financial Group
CFG
$30.4B
$17.5M 0.02%
+425,950
New +$17.2M
TSLA icon
540
CALL
Tesla
TSLA
$1.24T
$17.5M 0.02%
66,800
+63,800
+2,127% +$14.5M
ALNY icon
541
Alnylam Pharmaceuticals
ALNY
$36.3B
$17.5M 0.02%
+63,467
New +$16.5M
SJM icon
542
J.M. Smucker
SJM
$12.6B
$17.4M 0.02%
143,816
+73,840
+106% +$8.7M
WDFC icon
543
WD-40
WDFC
$3.1B
$17.3M 0.02%
67,184
-27,467
-29% -$6.89M
WAB icon
544
Wabtec
WAB
$51.1B
$17.2M 0.02%
+94,515
New +$15.5M
GGB icon
545
Gerdau
GGB
$9.44B
$17.1M 0.02%
4,890,126
-1,296,026
-21% -$4.24M
CPRX
546
DELISTED
Catalyst Pharmaceutical
CPRX
$17.1M 0.02%
860,934
-358,603
-29% -$6.65M
MDGL icon
547
Madrigal Pharmaceuticals
MDGL
$12.6B
$17.1M 0.02%
80,401
+78,701
+4,629% +$20.1M
FLEX icon
548
Flex
FLEX
$43.4B
$17M 0.02%
509,747
-626,663
-55% -$19.3M
TRMD icon
549
TORM
TRMD
$3.1B
$17M 0.02%
497,370
-932,619
-65% -$34.2M
HPQ icon
550
HP
HPQ
$23.5B
$17M 0.02%
474,046
+466,351
+6,060% +$16.4M

Similar funds

Marshall Wace's Q3 2024 Portfolio in Review

As of Q3 2024, Marshall Wace held 3,101 positions worth $82.1B, up 9.6% from $74.9B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Marshall Wace's Q3 2024 filing shows 616 new, 843 increased, 896 reduced and 659 closed positions. Its largest new stake was Texas Instruments: 1,008,812 shares worth $208M. The largest sale was Costco, an estimated $495M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q3 2024 buy was Texas Instruments: 1,008,812 shares worth $208M.
  • Marshall Wace added most to Tesla in Q3 2024, an estimated $700M increase.
  • Marshall Wace's biggest Q3 2024 reduction was Costco, cutting an estimated $495M.
  • Marshall Wace fully exited Shopify in Q3 2024, selling an estimated $209M.
  • Marshall Wace's ten largest holdings make up 34% of its $82.1B portfolio in Q3 2024.
  • Marshall Wace opened 616 new positions and closed 659 in Q3 2024.
  • Marshall Wace's portfolio value rose 9.6% quarter-over-quarter to $82.1B.

Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.